These results demonstrated that up-regulation of CXCL10, mainly through TLR4 signaling rather than CXCR3, mobilized and recruited monocytic MDSCs instead of granulocytic MDSCs to the liver to promote tumor recurrence. This evidence concerns the gene CXCR3 and neoplasm.